Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) and Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. Analyst Recommendations This is a summary of […]
Research Analysts Issue Forecasts for Entrada Therapeutics, Inc s Q3 2023 Earnings (NASDAQ:TRDA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Rating) – Stock analysts at HC Wainwright raised their Q2 2023 earnings per share (EPS) estimates for Entrada Therapeutics in a report released on Wednesday, May 24th. HC Wainwright analyst B. Pachaiyappan now expects that the company will earn ($0.23) per share for the quarter, up from their previous […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Rating) – Investment analysts at William Blair upped their Q2 2023 EPS estimates for Entrada Therapeutics in a research report issued on Wednesday, May 10th. William Blair analyst M. Minter now forecasts that the company will post earnings of ($0.62) per share for the quarter, up from their prior […]